[go: up one dir, main page]

CA2199707A1 - Inhibition de l'infection a rotavirus humain - Google Patents

Inhibition de l'infection a rotavirus humain

Info

Publication number
CA2199707A1
CA2199707A1 CA002199707A CA2199707A CA2199707A1 CA 2199707 A1 CA2199707 A1 CA 2199707A1 CA 002199707 A CA002199707 A CA 002199707A CA 2199707 A CA2199707 A CA 2199707A CA 2199707 A1 CA2199707 A1 CA 2199707A1
Authority
CA
Canada
Prior art keywords
casein
human
bovine
cells
kappa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002199707A
Other languages
English (en)
Inventor
Pradip Mukerji
Pedro Antonio Prieto
Amanda Eug-Yong Seo
Jeffrey Harris Baxter
Richard Dale Cummings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
University of Oklahoma
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/308,883 external-priority patent/US5576300A/en
Application filed by Individual filed Critical Individual
Publication of CA2199707A1 publication Critical patent/CA2199707A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Produit nutritionnel entérique contenant soit de la caséine ? humaine, soit de la caséine ? bovine en une concentration supérieure à celle que l'on trouve dans le lait humain ou bovin et suffisante pour inhiber l'infection de cellules mammaliennes par le rotavirus humain.
CA002199707A 1994-09-16 1995-05-05 Inhibition de l'infection a rotavirus humain Abandoned CA2199707A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30888294A 1994-09-16 1994-09-16
US08/308,883 US5576300A (en) 1994-09-16 1994-09-16 Method for inhibition of human rotavirus infection
US308,882 1994-09-16
US308,883 1994-09-16

Publications (1)

Publication Number Publication Date
CA2199707A1 true CA2199707A1 (fr) 1996-03-21

Family

ID=26976500

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002199707A Abandoned CA2199707A1 (fr) 1994-09-16 1995-05-05 Inhibition de l'infection a rotavirus humain

Country Status (7)

Country Link
EP (1) EP0784479A1 (fr)
JP (1) JPH10505828A (fr)
AU (1) AU711437B2 (fr)
CA (1) CA2199707A1 (fr)
MX (1) MX9701979A (fr)
NZ (1) NZ285593A (fr)
WO (1) WO1996008269A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028977B1 (fr) * 1997-09-16 2003-11-26 FORSSMANN, Wolf-Georg Peptides bifidogenes et leurs utilisations
CN101828713A (zh) 2003-03-14 2010-09-15 明治乳业株式会社 抗轮状病毒感染的组合物及制备该组合物的方法
RU2388485C2 (ru) 2005-09-30 2010-05-10 Моринага Милк Индастри Ко., Лтд. Стимулятор секреции глюкагон-подобного пептида 1, продукты питания или напитки, стимулирующие секрецию глюкагон-подобного пептида 1, ингибитор постпрандиальной гипергликемии и продукты питания или напитки, ингибирующие постпрандиальную гипергликемию

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JP2976349B2 (ja) * 1990-11-29 1999-11-10 雪印乳業株式会社 ｋ―カゼイングリコマクロペプチドの製造法
DK8892D0 (da) * 1992-01-23 1992-01-23 Symbicom Ab Humant proteingen
CA2148261A1 (fr) * 1992-10-30 1994-05-11 Jerry A. Peterson Produit anti-diarrhee et methode pour traiter l'infection associee au rotavirus
DK2193D0 (fr) * 1993-01-08 1993-01-08 Novo Nordisk As

Also Published As

Publication number Publication date
JPH10505828A (ja) 1998-06-09
WO1996008269A1 (fr) 1996-03-21
EP0784479A1 (fr) 1997-07-23
MX9701979A (es) 1997-06-28
NZ285593A (en) 1999-03-29
AU711437B2 (en) 1999-10-14
AU2474495A (en) 1996-03-29

Similar Documents

Publication Publication Date Title
Floris et al. Antibacterial and antiviral effects of milk proteins and derivatives thereof
Strömqvist et al. Human milk K‐casein and inhibition of Helicobacter pylori adhesion to human gastric mucosa
JP3100005B2 (ja) ヒト免疫不全ウィルス感染・増殖抑制剤
US5576300A (en) Method for inhibition of human rotavirus infection
TWI231213B (en) Anti-stress agent comprising a tripeptide of IPP or VPP and functional food
RU2579661C2 (ru) Способ производства лактоферрина, фракция, содержащая лактоферрин, и ее применения
US5667797A (en) Anti-viral composition and kit and use for treating rotavirus infection and diarrhea
CN101605557A (zh) 内切糖苷酶EndoS用于治疗免疫球蛋白G介导的疾病的用途
JP2013139477A (ja) 経口投与される剤
US3567821A (en) Medicament for the affections of mucous membranes
US5712250A (en) Product for inhibition of human rotavirus infection
AU1901501A (en) Antimcrobial activity of the first cationic cluster of human lactoferrin
JP3694319B2 (ja) 多量体アルファ−ラクトアルブミンを含有する抗菌組成物
AU711437B2 (en) Inhibition of human rotavirus infection
US5543392A (en) Digestive tract cell activating agent of EGF and lactoferrin
MXPA97001979A (en) Inhibition of infection by rotavirus hum
ES2291896T3 (es) Producto inmunomodulador obtenido a partir de un cultivo de bifidobacterium y composiciones que lo contienen.
JPH10500100A (ja) 哺乳動物細胞のｒｓウイルス感染の阻害
JP4014330B2 (ja) ウイルス感染防御剤
JP4208799B2 (ja) 炎症性サイトカイン産生抑制剤
JP4330088B2 (ja) タイトジャンクション透過抑制剤
JP4306828B2 (ja) 病原性細菌感染防御剤
JPH07179355A (ja) ＩｇＧおよびＩｇＭクラスの抗体産生を促進する 免疫賦活剤
WO2007107759A1 (fr) Peptide dérivé de colostrum
JP4313767B2 (ja) ヘリコバクター・ピロリ剥離作用を有するポリペプチド

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead